Strassheim D, Milligan G, Houslay M D
Institute of Biochemistry, University of Glasgow, Scotland, U.K.
Biochem J. 1990 Mar 1;266(2):521-6. doi: 10.1042/bj2660521.
Adipocyte membranes from control rats exhibited a functional Gi (inhibitory guanine-nucleotide-binding protein) activity which could be assessed either by the inhibitory action of low concentrations of guanosine 5-[beta gamma-imido]triphosphate (p[NH]ppG) upon forskolin-stimulated adenylate cyclase activity or by the inhibitory action of high concentrations of GTP upon isoprenaline-stimulated adenylate cyclase activity. When membranes from animals made diabetic with streptozotocin were used, then both such inhibitory functions of Gi were abolished. In contrast, receptor-mediated inhibitory responses of Gi, effected by N6-phenylisopropyl (adenosine), prostaglandin E2 or nicotinate, were either unchanged or even apparently more effective in membranes from diabetic animals. Induction of diabetes did not cause any change in the adipocyte plasma membrane levels of the alpha, GTP-binding subunits of either Gi1 or Gi2 or of Gs (stimulatory guanine-nucleotide-binding protein), but elicited an increase in the level of alpha-Gi3. The induction of diabetes reduced the specific activity of adenylate cyclase in adipocyte membranes and enhanced the stimulatory effect of isoprenaline. It is suggested that diabetes causes selective changes in the functioning of Gi in adipocyte membranes which removes the tonic GTP-dependent inhibitory function of this G-protein.
来自对照大鼠的脂肪细胞膜表现出功能性Gi(抑制性鸟嘌呤核苷酸结合蛋白)活性,这可以通过低浓度的鸟苷5-[βγ-亚氨基]三磷酸(p[NH]ppG)对福斯可林刺激的腺苷酸环化酶活性的抑制作用,或通过高浓度的GTP对异丙肾上腺素刺激的腺苷酸环化酶活性的抑制作用来评估。当使用来自用链脲佐菌素诱导糖尿病的动物的膜时,Gi的这两种抑制功能均被消除。相反,由N6-苯基异丙基(腺苷)、前列腺素E2或烟酸介导的Gi的受体介导的抑制反应在糖尿病动物的膜中要么未改变,要么甚至明显更有效。糖尿病的诱导并未导致Gi1或Gi2的α、GTP结合亚基或Gs(刺激性鸟嘌呤核苷酸结合蛋白)的脂肪细胞质膜水平发生任何变化,但引起α-Gi3水平的增加。糖尿病的诱导降低了脂肪细胞膜中腺苷酸环化酶的比活性,并增强了异丙肾上腺素的刺激作用。有人提出,糖尿病会导致脂肪细胞膜中Gi功能的选择性变化,从而消除该G蛋白的紧张性GTP依赖性抑制功能。